Related Experiment Video
Updated: Jul 5, 2025

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
Published on: September 18, 2015
Metal-Based Nanoparticles for Cardiovascular Diseases
Alexandru Scafa Udriște1, Alexandra Cristina Burdușel2, Adelina-Gabriela Niculescu2,3
1Department 4 Cardio-Thoracic Pathology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Metal nanoparticles offer new hope for cardiovascular diseases (CVDs), overcoming limitations of traditional treatments. This review explores metal and metal oxide nanoparticles for advanced CVD therapies.
Area of Science:
- Nanotechnology
- Materials Science
- Biomedical Engineering
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of death and disability.
- Existing CVD treatments often have limited efficacy and unfavorable side effects.
- Nanotechnology offers novel metal-based nanoparticles (NPs) with unique properties for therapeutic applications.
Purpose of the Study:
- To review the applications of metal and metal oxide nanoparticles in cardiovascular diseases (CVDs).
- To provide an updated framework for researchers developing novel CVD treatment strategies.
- To highlight the potential of nanotechnology in addressing limitations of current CVD therapies.
Main Methods:
- Literature review of metal and metal oxide nanoparticles.
- Analysis of nanoparticle properties (size, shape, composition).
- Evaluation of nanoparticle applications in CVDs, including imaging, drug delivery, and therapy.
Main Results:
- Metal-based NPs exhibit specialized physical, chemical, and biological properties.
- NPs show potential in molecular imaging, drug delivery, and thermal therapy for CVDs.
- Antimicrobial properties of NPs may also benefit cardiovascular health.
Conclusions:
- Metal and metal oxide nanoparticles represent a promising frontier in cardiovascular disease (CVD) treatment.
- Further research into these nanomaterials can lead to more effective and targeted CVD therapies.
- Nanotechnology provides innovative solutions to overcome challenges in managing cardiovascular diseases.
More Related Videos
11:37Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018
08:13Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
Published on: March 22, 2016
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...